However, the absence of CD10 expression and strongly positive expression for CD4, CD56, CD45RA, and the plasmacytoid dendritic cell-associated antigens, including CD123, supported the definite diagnosis of BPDCN. The gene discussed is CD4; the disease is CD4+/CD56+ hematodermic neoplasm.